Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation

PLoS ONE(2020)10.1371/journal.pone.0241551Source: DataRank Database

MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.43)OA: goldTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Alexis Santana,Nicole Doudican ORCID,N. Roudiani,Kristian B. Laursen ORCID,Jean‐Philippe Therrien ORCID

Live enrichment

PubMed:33227008 PMC:PMC7682861 OpenAlex:https://openalex.org/W3108904971

NIAMS NIH HHS

Grant: T32 AR064184

NCATS NIH HHS

Grant: UL1 TR001445

NCATS NIH HHS

Grant: TL1 TR001447

National Institutes of Health

Grant: 5T32AR064184-02

Cutaneous Biology and Skin Disease Training Program

National Institutes of Health

Grant: 2TL1TR001447-06A1

NRSA Training Core

FWCI

0.43

Citation Percentile

0.6%

Citation Trend

2021

2022

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0241551&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0241551&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0241551

journalhttps://doi.org/10.1371/journal.pone.0241551

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33227008

Fields of Study

Immunotherapy and Immune ResponsesHistiocytic Disorders and TreatmentsCancer Immunotherapy and Biomarkers0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

AnimalsAntibodiesAntigens, NeoplasmCarcinoma, Squamous CellCell CycleCollagenHumansNeoplasm InvasivenessNeoplasm ProteinsNeoplasm StagingPeripheral NervesPrognosisRNA, MessengerSkin NeoplasmsBiomarkers, TumorUp-RegulationCyclinsTreatment OutcomeMatrix MetalloproteinasesCell Line, TumorCell ProliferationMice

Keywords

Perineural invasionPathologyCancerCarcinomaMedicineCellCancer researchBiologyInternal medicineSkin NeoplasmsScienceAntibodiesMiceAntigens, NeoplasmCell Line, TumorCyclinsBiomarkers, TumorAnimalsHumansNeoplasm InvasivenessPeripheral NervesRNA, MessengerCell ProliferationNeoplasm StagingQCell CycleRPrognosisMatrix MetalloproteinasesNeoplasm ProteinsCarcinoma, Squamous CellCollagenResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: No povertySDG 0: Good health and well-being

MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)